← Open Payments lookup

ROSE ROMULUS: Open Payments

NPI 1770909236 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$545 in 27 payments from 11 companies in 2025. Trend: 2023 $520 · 2024 $299 · 2025 $545

Food & beverage: $545
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$232
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$111
Teva Pharmaceuticals USA, Inc.2$34
Lilly USA, LLC2$33
E.R. Squibb & Sons, L.L.C.1$28
Janssen Pharmaceuticals, Inc1$21
Exact Sciences Corporation1$21
ABBVIE INC.1$20
AstraZeneca Pharmaceuticals LP1$17
Amgen Inc.1$15

Products named: REXULTI, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, UZEDY, COBENFY, INVEGA SUSTENNA, Cologuard Collection Kit.

Industry payments across GA — which companies pay providers there.